Immune Response Clinical Trial
Official title:
LIFEHOUSE: a Lifestyle Intervention and Functional Evaluation- a Health OUtcome SurvEy; Description of the Tent Bucket -Immune Support
This immune support program will be an extension to the existing LIFEHOUSE program. Essential employees in Gig Harbor, WA; Colonial Heights, VA; Lenexa, KS, and Santa Fe Springs, CA, will be offered complimentary supplementation with commercially available nutritional supplements supportive of immune health for several months. The outcome will be measured via blood parameters and questionnaire responses.
This program, as a component of the LIFEHOUSE program, will consist of data collection during a period of supplementation with commercially available nutritional supplements supportive of immune health. Employees, in Gig Harbor, WA; Colonial Heights, VA; Lenexa, KS, and Santa Fe Springs, CA, will be offered the opportunity to participate. The nutritional and inflammatory status will be captured via fingerstick biomarkers. Participants will receive in-home testing kits including instructions regarding the applicable fingerstick blood collections. Fingerstick testing will include 25-Hydroxy Vitamin D3 (25-OH D3) and high sensitivity c-reactive protein (hs-CRP) measurements at baseline, 1, and 2 (phase 1), or at baseline 1,2, 3, and 6 months intervals (phase 2). Participants will also be asked to complete applicable questionnaires (QNs) electronically monthly using standard software programs for questionnaire completion. This will include the Medical Outcome Study (MOS) Short Form (SF) -36 (baseline and monthly) and Health Status QNs including questions on compliance, wellbeing, lifestyle (exercise, shifts worked, medications and supplements, and diet) (baseline and monthly). ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05515263 -
Snack Foods and Their Impact on the Immune Response Following Influenza Vaccination
|
N/A | |
Completed |
NCT02872311 -
Open-Label Influenza Vaccine Evaluation
|
N/A | |
Completed |
NCT01861613 -
Seroprevalence of Hepatitis B and Immune Response to Hepatitis B Vaccination in Chinese College Students
|
Phase 4 | |
Completed |
NCT03982069 -
Immunologic Response to FluMist vs. Flucelvax
|
Phase 4 | |
Recruiting |
NCT06041867 -
Agaricus Bisporus and Influenza Vaccination Response
|
N/A | |
Completed |
NCT03614975 -
Immunologic Response to Influenza Vaccination in Children and Adolescents
|
Phase 4 | |
Completed |
NCT04573543 -
The Role of Immune Semaphorins in NAFLD
|
||
Recruiting |
NCT03875703 -
Post-Vaccination Biological Collection
|
||
Completed |
NCT00902278 -
Immune Responses Induced by Different Licensed Influenza Vaccines
|
N/A | |
Completed |
NCT00346619 -
Determining the Amount of Time Needed for Nelfinavir to Boost the Immune System in Adults
|
Phase 1 | |
Recruiting |
NCT04274348 -
Staphylococcal Toxins in Atopic Dermatitis and Eczema Herpeticum
|
N/A | |
Active, not recruiting |
NCT05534893 -
Effect of Blueberries on Immunity and Response to Flu Vaccination
|
N/A | |
Completed |
NCT05970887 -
Immunogenicity and Safety of Concomitant Administration of Bivalent COVID-19 Vaccines With Influenza Vaccines
|
Phase 4 | |
Completed |
NCT05706350 -
Plant Stanol Esters and Influenza Vaccination
|
N/A | |
Completed |
NCT03167593 -
Effects of Lactobacillus Coryniformis CECT5711 on Immune Response to Influenza Vaccination in Adults Over 65.
|
Phase 2 | |
Completed |
NCT04386408 -
Evaluation of the Effect of a Combination of Plant Extracts (BSL_EP027) on the Incidence of Respiratory Infections
|
Phase 1 | |
Completed |
NCT02933931 -
Immune Durability After VSV-EBOV Vaccination
|
||
Recruiting |
NCT01289535 -
Immune Response Analysis to Influenza Vaccine in Elderly Aged Over 65 Years
|
Phase 4 | |
Active, not recruiting |
NCT02441426 -
Interactions of Enteric Infections and Malnutrition and the Consequences for Child Health and Development
|
N/A | |
Recruiting |
NCT03399357 -
Evaluation of Metabolic Predictors of Influenza Vaccine Immune Response in the Singapore Elderly Population - the DYNAMIC Trial
|
N/A |